Spirometry ENG – Chapter 10 Self-assessment Quiz

10.1 What is a positive bronchodilator test?

10.2 Match each of the descriptions to the most appropriate label in the below:

10.3 What dosage of short-acting b2-agonist, Salbutamol, should be administered when conducting a bronchodilator responsiveness test and using a jet nebulizer?

10.4 With regards to the bronchodilator responsiveness testing in spirometry place the correct words in the correct spaces in the sentence below:

Word options:

Word options:

10.5 Select true or false for the following statements:

a. The aim of bronchodilator responsiveness testing is to assess possible relaxation of bronchial muscle resulting in expansion of the bronchial air passages

b. One of the indications for bronchodilator responsiveness testing is to guide treatment decisions

c. The contraindications to undertaking bronchodilator responsiveness testing are mainly involved with the use of beta-agonist inhalers

d. It is very important to document what medication, the type and dosage, and when it was last taken prior to testing so that the test can be interpreted correctly

10.6 The following washout times are applicable as part of preparing for spirometry bronchodilator responsiveness testing:                                                                                                                                        

Please indicate below whether each of the statements above are True or False:

a.  Workers should avoid using Short-acting b2-agonist (SABAs) Salbutamol, 6 – 8 hours prior to testing.

b. Workers should avoid using Short-acting muscarinic antagonists (SAMAs) e.g. Ipratropium bromide, 12 hours prior to testing.

c.  Workers should avoid using Long-acting b2-agonist (LABAs) e,g, Formoterol or Salmeterol (including combination inhalers) or twice daily preparations, 12 hours prior to testing.

d.  Workers should avoid using Ultra-LABA (e.g., indacaterol, vilanterol, or olodaterol), 24 hours prior to testing.

e.  Workers should avoid using Long-acting muscarinic antagonists (LAMAs) Tiotropium, umeclidinium, aclidinium, or glycopyrronium or once-daily preparations, 36 – 48 hours prior to testing.

10.7 What dosage of short-acting b2-agonist, Salbutamol, should be administered when conducting a bronchodilator responsiveness test and using a MDI and spacer?

10.8 How long should you wait for the bronchodilator to take effect before conducting the post bronchodilator test?

10.9  Look at the bronchodilator test below. Is this a positive or negative test result?